Johns Hopkins Medicine

Radiation of a primary tumor can activate immune cells around distant metastases, a study by Valsamo Anagnostou, a cancer researcher at Johns Hopkins, and colleagues has shown. Anagnostou says the mechanism is clear.  Anangostou: Radiation induces cell death. The cells …

How does radiation benefit the body’s response to cancer? Elizabeth Tracey reports Read more →

In part x, we’ve reached Appendix J, which is the final JHEBP tool. Join Judy Ascenzi, Director of Pediatric Nursing Programs at Johns Hopkins Children’s Center and Heather Watson, Johns Hopkins Health System Nurse Scientist discuss how Appendix J promotes …

Episode 73: Appendix J – 5th Edition (Part 11) | Johns Hopkins Center for Nursing Inquiry Read more →

When cancer develops resistance to immunotherapy, radiation may help. That’s according to a study by cancer researcher Valsamo Anagnostou at Johns Hopkins. Anagnostou: We’re administering radiation as a sensitizer for immunotherapy and as the way to circumvent primary resistance to …

Radiation is emerging as an important tool in helping improve immune response in cancer, Elizabeth Tracey reports Read more →

If someone with cancer has initially responded to immunotherapy but then develops metastasis, radiation of the primary tumor may help treat those distant sites, research by Valsamo Anagnostou, a cancer researcher at Johns Hopkins, has shown. Anagnostou: Radiation can activate …

Can radiation affect distant metastasis? Elizabeth Tracey reports Read more →

Immunotherapies have proven very successful in the treatment of different types of cancer, but over time it is common for resistance to develop. Valsamo Anagnostou, a cancer researcher at Johns Hopkins, has found that radiation may help activate someone’s own …

Can radiation improve the success of immunotherapies to treat cancer? Elizabeth Tracey reports Read more →

How tumors respond to treatment has to do with both their internal and external environments, research by Valsamo Anagnostou, a cancer researcher at Johns Hopkins, and colleagues has shown. Anagnostou: The way we do this is by looking very deeply …

What does the area around a tumor tell us about response to treatment? Elizabeth Tracey reports Read more →

Immunotherapies hold enormous promise for treating cancers of various types, but the bad news is that while many patients may initially respond many will also become resistant. Valsamo Anagnostou, a cancer researcher at Johns Hopkins, is looking at tumor specific …

Assessing individual cancer characteristics is needed to determine resistance to new types of therapies, Elizabeth Tracey reports Read more →

GLP-1 medications like Ozempic and Wegovy are generating major buzz for weight loss — but what’s fact, what’s fiction and what do they really do in the body? In this extended episode, Dr. Selvi Rajagopal, a Johns Hopkins internist, pediatrician, …

Ep 3: Inside GLP-1s: How They Work, Who They Help & What to Expect | Medicine Made General Read more →

Join a conversation with Dr. Carolyn Cumpsty Fowler, JHHS Executive Director for Nurse Well-Being and Dr. Cassie O'Malley, Senior Director of Well-being and Innovation, MedStar Health, on how healthcare leaders can create supportive environments that foster inter-disciplinary team well-being. The …

Ep. 17 Well-Being by Design: Building Systems That Support the Whole Team | Johns Hopkins Medicine Office of Well-Being Read more →